Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-16

Clinical Trial Update: Autologous Cell Therapy for Treatment of Fecal Incontinence [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of an autologous cell therapy for fecal incontinence has completed recruitment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous cell therapy (Cook MyoSite)

Snippet

Sponsor: Cook MyoSite | Conditions: Fecal Incontinence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-16